Marianna Menozzi to Male
This is a "connection" page, showing publications Marianna Menozzi has written about Male.
Connection Strength
0.036
-
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study. PLoS One. 2021; 16(8):e0251378.
Score: 0.003
-
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19. Clin Exp Nephrol. 2021 Nov; 25(11):1203-1214.
Score: 0.003
-
Acid base disorders in patients with COVID-19. Int Urol Nephrol. 2022 Feb; 54(2):405-410.
Score: 0.003
-
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia. AIDS Res Hum Retroviruses. 2021 04; 37(4):283-291.
Score: 0.003
-
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
Score: 0.003
-
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect. 2021 Aug; 27(8):1137-1144.
Score: 0.003
-
Hypokalemia in Patients with COVID-19. Clin Exp Nephrol. 2021 Apr; 25(4):401-409.
Score: 0.003
-
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency. PLoS One. 2020; 15(11):e0239172.
Score: 0.003
-
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study). Clin Microbiol Infect. 2020 Nov; 26(11):1545-1553.
Score: 0.003
-
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020 07 06; 11(1):3434.
Score: 0.003
-
Incidence of HCV infection amongst HIV positive men who had sex with men and prevalence data from patients followed at the Infectious Diseases Clinic of Modena, Italy. Dig Liver Dis. 2018 12; 50(12):1334-1338.
Score: 0.003
-
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study. AIDS Res Ther. 2017 Feb 16; 14(1):8.
Score: 0.002